We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Cooley-Led Allogene Raises $324M After IPO Prices High

Law360 (October 11, 2018, 2:45 PM EDT) -- California-based clinical-stage biotechnology company Allogene Therapeutics Inc. started trading on the Nasdaq Global Select Market on Thursday after the Cooley LLP-led company priced its $324 million initial public offering at the high...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.